Skip to main content

Advertisement

Log in

Molecular alteration of the proteasome contributes to AD-like pathology in the brain of HFD-STZ diabetic rats

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

Diabetes-related cognitive impairment has been shown in diverse epidemiological investigations and lab-based studies, although the underlying pathological mechanisms remain unclear. Unbalanced protein homeostasis may contribute to cognitive decline by inducing abnormal protein aggregation in the diabetic brain. This study aimed to determine possible changes in the proteasome, which is an important pathway involved in abnormal protein degradation. To this end, we examined potential alterations of proteasomal subunits and hydrolytic activity in the brain of diabetic rats fed with high-fat diet combined with small doses of streptozotocin (STZ). Furthermore, lactacystin were used to inhibit proteasomal activity in vivo and typical Alzheimer’s disease (AD)-like pathologies were detected, including amyloid-beta, tau phosphorylation, and oxidative protein changes. Our results showed that proteasomal activity increased in the brains of diabetic rats compared to age-matched control rats. After proteasome inhibition, the levels of tau phosphorylation and protein oxidative modification significantly increased; however, no changes were detected in the pathway involved in amyloid production. These results indicated that changes in protein homeostasis balance in diabetes play a role in some typical AD-like changes, especially in oxidative protein degradation, providing evidence that prevention of diabetes-induced protein imbalance may be a potential therapeutic target.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The datasets generated during the current study are available from the corresponding author on reasonable request.

References

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (NSFC) No.81541116 and No.81760236 to ZHAO Bei. Thanks to Dr. KUNDU for his kindly help in English revision during review process.

Funding

This work was supported by the National Natural Science Foundation of China (NSFC) No.81541116 and No.81760236 to ZHAO Bei.

Author information

Authors and Affiliations

Authors

Contributions

Gao Han and Zhou Ye, biochemistry experiment and manuscript writing. Jin peng-shuai and Wu Dong-gui, work in diabetic rat model establishment. Wang Yu-na and Zhao Xi, work in data analysis.

Corresponding author

Correspondence to Bei Zhao.

Ethics declarations

Ethics approval

Animal experiment was carried out in accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80–23) and the animal experiments procedures involved in this experiment were approved by the animal ethics committee of Dali University.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Financial interests

All authors declare have no financial interests in this work.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, H., Zhou, Y., Jin, Ps. et al. Molecular alteration of the proteasome contributes to AD-like pathology in the brain of HFD-STZ diabetic rats. Metab Brain Dis 38, 1013–1024 (2023). https://doi.org/10.1007/s11011-022-01151-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-022-01151-w

Keywords

Navigation